Related Experiment Videos
Influenza vaccination in asthma: a primary care experience
A Innes1, E Beresford, J Bedford
1Astra Pharmaceuticals Ltd, King's Langley, Hertfordshire.
Summary
Annual influenza vaccination is safe for asthma patients in primary care, despite some concerns about side effects. This study found no significant negative impact on lung function, encouraging higher vaccination rates.
Area of Science:
- Pulmonology
- Immunology
- General Practice
Background:
- Low uptake of annual influenza vaccination in asthma patients, contrary to health recommendations.
- Patient apprehension regarding potential harm from influenza vaccination.
Purpose of the Study:
- To assess the safety and effects of influenza vaccination in asthma patients within a general practice setting.
- Evaluate the impact of influenza vaccination on key asthma indicators.
Main Methods:
- Multicenter study involving 56 asthma patients across 14 UK general practices.
- Collected data on peak expiratory flow rate (PEFR) and symptom diaries for two weeks pre- and post-vaccination.
Main Results:
- A minor, non-significant decrease in PEFR (2%) was observed post-vaccination.
- A significant increase in nighttime reliever medication use (0.17 puffs/night) was noted.
- Non-significant increases in sleep disturbance, symptom severity, and daytime reliever use.
Conclusions:
- Influenza vaccination is confirmed as safe for primary care asthma patients.
- General practitioners should confidently recommend influenza vaccination to improve patient health outcomes.
- Strategies to enhance influenza vaccination uptake in asthmatics are needed.